Global expression analysis of microRNAs in paired initial and relapsed glioblastoma

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

ŠÁNA Jiří BEŠŠE Andrej LAKOMÝ Radek KŘEN Leoš KOSAŘOVÁ Zdeňka FADRUS Pavel ŠLAMPA Pavel SMRČKA Martin VYZULA Rostislav SLABÝ Ondřej

Year of publication 2013
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Description Glioblastoma multiforme (GBM) is the most commonly occurring primary brain tumour. Despite modern therapeutic approaches based on a radical resection, concomitant chemoradiotherapy with temozolomide and adjuvant chemotherapy, the median of overall survival is around 15 months from diagnosis. This infaust prognosis is mainly caused by GBM resistance to the indicated therapy. Therefore, it is very important to find new biomarkers, which will predict a clinical outcome of GBM patients who have undergone therapy with themozolomide. Recent studies show, that miRNAs could play an important role in chemo- and radioresistance of many tumours including GBM.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.